Park Avenue Securities LLC cut its stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 5.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,638 shares of the business services provider’s stock after selling 298 shares during the quarter. Park Avenue Securities LLC’s holdings in Exponent were worth $502,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently made changes to their positions in the stock. Quarry LP bought a new stake in shares of Exponent during the 2nd quarter valued at about $25,000. Westside Investment Management Inc. purchased a new position in shares of Exponent in the third quarter valued at about $26,000. USA Financial Formulas bought a new position in Exponent in the 3rd quarter worth approximately $60,000. Anchor Investment Management LLC purchased a new stake in Exponent during the 3rd quarter valued at approximately $64,000. Finally, GAMMA Investing LLC raised its position in shares of Exponent by 64.6% during the third quarter. GAMMA Investing LLC now owns 624 shares of the business services provider’s stock valued at $72,000 after buying an additional 245 shares during the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Exponent
In related news, Director Paul R. Johnston sold 14,000 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the sale, the director now owns 80,742 shares of the company’s stock, valued at $8,445,613.20. This represents a 14.78 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the transaction, the director now directly owns 5,871 shares of the company’s stock, valued at $565,494.72. The trade was a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,339 shares of company stock valued at $3,103,065 in the last 90 days. Insiders own 2.10% of the company’s stock.
Exponent Stock Performance
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- What is an Earnings Surprise?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Canadian Penny Stocks: Can They Make You Rich?
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- How to Evaluate a Stock Before Buying
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.